Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting
Pedram Yadollahi
Kelli A. McCord
Yang Li
Hussam Dayoub
Kalil Saab
Fonma Essien
Sean Hyslop
Emerald Kan
Kazi M. Ahmed
Parker R. Kirby
Vasanta Putluri
Chandra Shekar. R. Ambati
Karthik Reddy Kami Reddy
Patricia Castro
Heath D. Skinner
Cristian Coarfa
William K. Decker
Abdullah A. Osman
Rutulkumar Patel
Jeffrey N. Myers
Stephen Y. Lai
Nagireddy Putluri
Faye M. Johnson
Mitchell J. Frederick
William H. Hudson
Vlad C. Sandulache
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41416-025-03189-w
Oct 6, 2025
Version published to 10.1101/2025.01.10.632413 on bioRxiv
Jan 14, 2025
Related articles
TAS2R10
Suppresses ABCG2 Transporter-Associated Chemoresistance and Enhances Cisplatin Sensitivity in Head and Neck Squamous Cell Carcinoma
This article has 9 authors:
Lily Huang
Sarah M. Sywanycz
Priyanka Sahu
Leilei Hao
Kyle Polen
Gavin Turner
Zoey A. Miller
Robert J. Lee
Ryan M. Carey
Cisplatin-Induced Plasticity Drives Cross-Resistance to CDK4/6 Inhibitors and Reveals Targetable Vulnerabilities Through HDAC Inhibition in Esophageal Squamous Cell Carcinoma
This article has 6 authors:
Marta Ávalos-Moreno
Aurora Vigato
Fabiana Moresi
Diego Japón-Ruiz
Benjamin Beck
Xavier Bisteau
Targeting CBP/p300 Overcomes Acquired Vincristine Resistance in Medulloblastoma
This article has 10 authors:
Goktug Karabiyik
Ozlem Yedier-Bayram
Filiz Senbabaoglu Aksu
Tolga Lokumcu
Ali Cenk Aksu
Fidan Seker-Polat
Ezgi Ozyerli-Goknar
Adam P Cribbs
Udo Oppermann
Tugba Bagci-Onder
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In